by RIVANNA | Oct 21, 2025 | Press Releases
CHARLOTTESVILLE, VA, OCTOBER 21, 2025 — RIVANNA®, developer of world-first imaging-based medical technologies, has recently been awarded with a Peer-Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) from the Congressionally...
by RIVANNA | Oct 15, 2025 | News
Healthcare economics have never been more challenging. Rising costs, flat reimbursements, and pressure for quality outcomes mean every clinical decision has a financial impact. At the same time, payers are stripping away traditional payment modifiers, making it harder...
by RIVANNA | Oct 7, 2025 | News
For hospital healthcare executives, navigating the complex landscape of clinical outcomes, patient satisfaction, and financial performance is a constant balancing act. Within this landscape, neuraxial anesthesia, which is a cornerstone of modern surgical and obstetric...
by RIVANNA | Oct 2, 2025 | Press Releases
CHARLOTTESVILLE, VA, OCTOBER 2, 2025 — RIVANNA®, developer of world-first imaging-based medical technologies, today announced it has been named a finalist in MedTech Innovator’s (MTI) 2025 Early-Stage Grand Prize competition. The recognition comes as part of the...
by RIVANNA | Sep 8, 2025 | Video
Military medical device development requires more than adapting existing technology; it demands understanding operational realities from the ground up. The Accuro 3S-MIL development process exemplified this approach through a comprehensive 36-month timeline that...
